CLINICAL_TRIALS
trial_result
· 2019-01-25
Clinical Trial Update: Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis [Phase 2]
Summary
Phase 2 clinical trial evaluating riociguat for systemic sclerosis has completed; results posted in 2019 with data on efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Scleroderma, Systemic | Phase 2 | Status: COMPLETED | Results posted: 2019-01-25